Meridian Bioscience Inc
VIVO
VIVO was delisted on the 30th of January, 2023.
183 hedge funds and large institutions have $701M invested in Meridian Bioscience Inc in 2019 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 80 increasing their positions, 46 reducing their positions, and 25 closing their positions.
3,212% more call options, than puts
Call options by funds: $1.99M | Put options by funds: $60K
74% more repeat investments, than reductions
Existing positions increased: 80 | Existing positions reduced: 46
2% more capital invested
Capital invested by funds: $690M → $701M (+$11.4M)
4% less funds holding
Funds holding: 191 → 183 (-8)
28% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 25
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VNIM
Vaughan Nelson Investment Management
Houston,
Texas
|
+$11.6M |
| 2 |
State Street
Boston,
Massachusetts
|
+$3.03M |
| 3 |
Goldman Sachs
New York
|
+$2.96M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.42M |
| 5 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
+$2.26M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
-$10M |
| 2 |
WG
Winton Group
London,
United Kingdom
|
-$3.72M |
| 3 |
Hotchkis & Wiley Capital Management
Los Angeles,
California
|
-$2.83M |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$2.63M |
| 5 |
Morgan Stanley
New York
|
-$2.59M |
VIVO Hedge Fund Activity: Q1 2019 in Review
183 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Meridian Bioscience Inc (VIVO) for Q1 2019, worth a combined $701M — up 1.6% from $690M a quarter earlier.
Sellers outnumbered buyers: 25 funds closed out of VIVO and 18 opened new positions — a net loss of 7 holders — while 46 trimmed existing stakes and 80 added.
The largest buyer was Vaughan Nelson Investment Management, adding an estimated $11.6M. The largest seller was Invesco, cutting an estimated $10M.
- 183 institutional investors held Meridian Bioscience Inc (VIVO) as of Q1 2019, down from 191 in Q4 2018.
- Funds reported $701M of Meridian Bioscience Inc stock for Q1 2019, up 1.6% quarter-over-quarter.
- 18 funds opened new Meridian Bioscience Inc positions in Q1 2019 and 25 closed out, a net change of -7 holders.
- The largest Meridian Bioscience Inc buyer in Q1 2019 was Vaughan Nelson Investment Management, an estimated $11.6M added.
- The largest Meridian Bioscience Inc seller in Q1 2019 was Invesco, an estimated $10M sold.
Based on aggregated 13F filings for Q1 2019.